Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP-Reference-Cited by-同舟云学术

Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP

Published:2017-10-09 Issue:5 Volume:103 Page:854-867
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Tan Ming-Liang¹,Yoshida Kenta¹²,Zhao Ping¹,Zhang Lei¹,Nolin Thomas D.³,Piquette-Miller Micheline⁴,Galetin Aleksandra⁵,Huang Shiew-Mei¹

Affiliation:

1. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research; U.S. Food and Drug Administration; Silver Spring Maryland USA

2. Current affiliation: Clinical Pharmacology; Genentech Research and Early Development; South San Francisco California USA

3. Center for Clinical Pharmaceutical Sciences, Department of Pharmacy and Therapeutics, and Department of Medicine Renal-Electrolyte Division; University of Pittsburgh Schools of Pharmacy and Medicine; Pittsburgh Pennsylvania USA

4. Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto Ontario Canada

5. Centre for Applied Pharmaceutical Research, School of Heath Sciences; University of Manchester; Manchester UK

Funder

US Food and Drug Administration's (FDA's) Medical Countermeasures Initiative

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. The effects of CKD on cytochrome P450-mediated drug metabolism;Ladda;Adv. Chronic Kidney Dis.,2016

2. Chronic kidney disease: global dimension and perspectives;Jha;Lancet,2013

3. Public health consequences of chronic kidney disease;Weiner;Clin. Pharmacol. Ther.,2009

4. Risk factors associated with adverse drug events among older adults in emergency department;Chen;Eur. J. Intern. Med.,2014

5. Emerging evidence of the impact of kidney disease on drug metabolism and transport;Nolin;Clin. Pharmacol. Ther.,2008

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients;British Journal of Clinical Pharmacology;2023-12-10

2. Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes;The Journal of Clinical Pharmacology;2023-11-02

3. Part II: Interactive case: Critical evaluation of kidney function;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-10

4. Development of 4‐Pyridoxic Acid PBPK Model to Support Biomarker‐Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease;Clinical Pharmacology & Therapeutics;2023-09-08

5. Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney Dysfunction;DRUG METAB DISPOS;2023